Nitrofurantoin-induced BOOP was diagnosed on the basis of CT and bronchoscopy findings and the timing of symptom onset in relation to initiation of nitrofurantoin treatment. The patient was extubated on day 8 after admission and was transferred to the general medicine ward on day 13. For instance I finished my levaquin treatment of 10 days for my current infection then was put on 15 days of macrobid. The urologist says that I am going to be fine but I do not see this ending. The study is based on nitrofurantoin; nitrofurantoin, macrocrystalline (the active ingredients of Macrobid) and Macrobid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Pneumonia are also considered in the study. Bronchiolitis obliterans organizing pneumonia due to nitrofurantoin has rarely been reported and is associated with poor outcomes. A case of nitrofurantoin-associated bronchiolitis obliterans organizing pneumonia responsive to drug withdrawal and corticosteroids is presented. The role of corticosteroid therapy in the treatment of chronic nitrofurantoin-induced lung disease remains controversial. There is no clear evidence that corticosteroid therapy is beneficial in the management of chronic nitrofurantoin-induced lung disease on the basis of previous reports in the literature or from the current study. Given the relative rarity of this condition, it seems unlikely. Nitrofurantoin is an antibiotic that is used for treating urinary tract infections caused by several types of bacteria. It is effective against E. Coli, Enterobacter cystitis, Enterococcus, Klebsiella, and Staphylococcus aureus. I have been prone to both pneumonia and UTI's. I've had C. diff. three times - always associated with an antibiotic - first time Vantin, second time Levaquin, third time ampicillin. Gupta and Trautner suggest using nitrofurantoin as prophylaxis for recurrent urinary tract infections (UTIs) in non-pregnant women.1 They mention the risk of pulmonary toxicity (“nitrofurantoin lung”) associated with prolonged treatment but suggest that this occurs after years of treatment. Nitrofurantoin is an antibacterial agent frequently used in the management of urinary tract infections (UTIs). This antimicrobial drug is generally used for treatment of acute cystitis and for prophylaxis in patients with recurrent UTIs. Pulmonary toxicity due to nitrofurantoin has two main Nitrofurantoin has been widely used for the treatment and prevention of recurrent urinary tract infections since its introduction into clinical practice in 1953. 1,2 Although it continues to be an effective antibiotic, nitrofurantoin is associated with several adverse effects, including pulmonary toxicity.